Targeting the PI3K/Akt/mTOR pathway in estrogen-receptor positive HER2 negative advanced breast cancer.
Ther Adv Med Oncol. 2020 Jul 28;12:1758835920940939. doi: 10.1177/1758835920940939. eCollection 2020.
Ther Adv Med Oncol. 2020.
PMID: 32782489
Free PMC article.
Review.